Graeme Bell has been responsible for the financial operations of several companies, including capital formation & relationships with the capital markets. He has also overseen IT, pre-commercialization strategic planning and activities to support the pipeline and other operational aspects, including working closely with external partners. Graeme's working style is to collaborate with cross-functional teams in clinical, regulatory, corporate development, manufacturing, market access, and human resources to optimize the business. With a distinguished 30-year career and as a top financial executive in the biopharmaceutical sector, Graeme brings strong financial and commercial credentials, management expertise, and a reputation for integrity. He couples solid strategic governance, finance, and control skills with a natural communication ability to inform decisions, challenge the status quo, and facilitate consensus among diverse stakeholders. He is interested in serving as an independent advisor on the board(s) of emerging/midsize biopharmaceutical companies.